eli lilly phase 3 trial retatrutide Shows 28% Weight Loss in 80 Weeks Eli Lilly's Phase 3 data

A controlled trial of intermittent oral acetylcysteine in the long-term treatment of chronic bronchitis

This state, hypoglycemia unawareness , is likely the result of repeated iatrogenic hypoglycemia episodes that lead to impaired epinephrine response and diminished neurogenic symptoms

While some experts and researchers have concerns about the drugs long-term impact and safety, many argue the benefits outweigh the known risks.

For older men losing weight on GLP-1 medications, most sports medicine and geriatric nutrition guidelines suggest going higher, in the range of 1.2 to 1.6 grams per kilogram, to offset age-related reductions in muscle protein synthesis efficiency